These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 29305201)

  • 1. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper-Urinary-Tract Effects After Irreversible Electroporation (IRE) of Human Localised Renal-Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Ablate-and-Resect Study.
    Wendler JJ; Pech M; Köllermann J; Friebe B; Siedentopf S; Blaschke S; Schindele D; Porsch M; Baumunk D; Jürgens J; Fischbach F; Ricke J; Schostak M; Böhm M; Liehr UB
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):466-476. PubMed ID: 28929209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
    Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
    Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
    BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study.
    Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM
    Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience.
    Trimmer CK; Khosla A; Morgan M; Stephenson SL; Ozayar A; Cadeddu JA
    J Vasc Interv Radiol; 2015 Oct; 26(10):1465-71. PubMed ID: 26250855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience.
    Wah TM; Lenton J; Smith J; Bassett P; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Kimuli M; Cartledge J
    Eur Radiol; 2021 Oct; 31(10):7491-7499. PubMed ID: 33825033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes.
    Dai JC; Morgan TN; Steinberg RL; Johnson BA; Garbens A; Cadeddu JA
    J Endourol; 2021 Nov; 35(11):1586-1592. PubMed ID: 33926224
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible electroporation (IRE): a novel method for renal tissue ablation.
    Tracy CR; Kabbani W; Cadeddu JA
    BJU Int; 2011 Jun; 107(12):1982-7. PubMed ID: 21044244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.
    Wagstaff PG; de Bruin DM; Zondervan PJ; Savci Heijink CD; Engelbrecht MR; van Delden OM; van Leeuwen TG; Wijkstra H; de la Rosette JJ; Laguna Pes MP
    BMC Cancer; 2015 Mar; 15():165. PubMed ID: 25886058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided ablation of renal cell carcinoma.
    Wah TM
    Clin Radiol; 2017 Aug; 72(8):636-644. PubMed ID: 28527529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b).
    Buijs M; van Lienden KP; Wagstaff PG; Scheltema MJ; de Bruin DM; Zondervan PJ; van Delden OM; van Leeuwen TG; de la Rosette JJ; Laguna MP
    JMIR Res Protoc; 2017 Feb; 6(2):e21. PubMed ID: 28209559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
    van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
    Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
    Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings.
    Permpongkosol S; Link RE; Solomon SB; Kavoussi LR
    J Urol; 2006 Aug; 176(2):463-7; discussion 467. PubMed ID: 16813865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study.
    Pech M; Janitzky A; Wendler JJ; Strang C; Blaschke S; Dudeck O; Ricke J; Liehr UB
    Cardiovasc Intervent Radiol; 2011 Feb; 34(1):132-8. PubMed ID: 20711837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible Electroporation for Surgical Renal Masses in Solitary Kidneys: Short-Term Interventional and Functional Outcome.
    Diehl SJ; Rathmann N; Kostrzewa M; Ritter M; Smakic A; Schoenberg SO; Kriegmair MC
    J Vasc Interv Radiol; 2016 Sep; 27(9):1407-1413. PubMed ID: 27292599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.